Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score

Journal of the American College of Cardiology

Volumn 45, Issue 9, 2005, Pages 1397-1405

  Halkin, Amir ^a   Singh, Mandeep ^b   Nikolsky, Eugenia ^a   Grines, Cindy L ^c   Tcheng, James E ^d   Garcia, Eulogio ^e   Cox, David A ^f   Turco, Mark ^g   Stuckey, Thomas D ^h   Na, Yingo ^a   Lansky, Alexandra J ^a   Gersh, Bernard J ^b   O'Neill, William W ^c   Mehran, Roxana ^a   Stone, Gregg W ^a,i  

^a NewYork Presbyterian Hospital   (United States)

^b MAYO CLINIC   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f Mid Carolina Cardiology   (United States)

^g WASHINGTON ADVENTIST HOSPITAL   (United States)

^h MOSES H CONE MEMORIAL HOSPITAL   (United States)

ⁱ CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD CLOT LYSIS; CORONARY STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL MODEL; SURVIVAL;

EID: 20944448236     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.01.041     Document Type: Article

References (41)

1. E.C. Keeley, J.A. Boura, C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction a quantitative review of 23 randomised trials Lancet 361 2003 13 20
2. K.L. Lee, L.H. Woodlief, E.J. Topol Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 1995 1659 1668
3. C. Fresco, F. Carinci, A.P. Maggioni Very early assessment of risk for in-hospital death among 11,483 patients with acute myocardial infarction GISSI investigators Am Heart J 138 1999 1058 1064
4. D.A. Morrow, E.M. Antman, A. Charlesworth TIMI risk score for ST-elevation myocardial infarction a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy Circulation 102 2000 2031 2037
5. D.A. Morrow, E.M. Antman, R.P. Giugliano A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction an InTIME II substudy Lancet 358 2001 1571 1575
6. B.L. Zaret, F.J. Wackers, M.L. Terrin Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis In Myocardial Infarction (TIMI) phase II study. The TIMI Study Group J Am Coll Cardiol 26 1995 73 79
7. M. Singh, G.S. Reeder, S.J. Jacobsen, S. Weston, J. Killian, V.L. Roger Scores for post-myocardial infarction risk stratification in the community Circulation 106 2002 2309 2314
8. S. Addala, C.L. Grines, S.R. Dixon Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score) Am J Cardiol 93 2004 629 632
9. G. De Luca, H. Suryapranata, W.J. Arnoud Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty Implications for early discharge Circulation 109 2004 2737 2743
10. P.J. de Feyter, E. McFadden Risk score for percutaneous coronary intervention forewarned is forearmed J Am Coll Cardiol 42 2003 1729 1730
11. G.W. Stone, C.L. Grines, D.A. Cox Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
12. C.L. Grines, D.A. Cox, G.W. Stone Coronary angioplasty with or without stent implantation for acute myocardial infarction Stent Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 341 1999 1949 1956
13. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial Phase I findings N Engl J Med 312 1985 932 936
14. H.T. Dodge, H. Sandler, D.W. Ballew, J.D. Lord Jr The use of biplane angiocardiography for the measurement of left ventricular volume in man Am Heart J 60 1960 762 776
15. F.H. Sheehan, E.L. Bolson, H.T. Dodge, D.G. Mathey, J. Schofer, H.W. Woo Advantages and applications of the centerline method for characterizing regional ventricular function Circulation 74 1986 293 305
16. E. Nikolsky, E.D. Aymong, A. Halkin Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial J Am Coll Cardiol 44 2004 547 553
17. H.M. Sadeghi, G.W. Stone, C.L. Grines Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 2003 2769 2775
18. G. Guagliumi, G.W. Stone, D.A. Cox Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial Circulation 110 2004 1598 1604
19. Nutritional anaemias Report of a WHO scientific group World Health Organ Tech Rep Ser 405 1968 5 37
20. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
21. K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
22. F.E. Harrell Jr, K.L. Lee, D.B. Mark Multivariable prognostic models issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
23. D.E. Cutlip, K.K. Ho, R.E. Kuntz, D.S. Baim Risk assessment for percutaneous coronary intervention our version of the weather report? J Am Coll Cardiol 42 2003 1896 1899
24. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves a nonparametric approach Biometrics 44 1988 837 845
25. D.A. Morrow, E.M. Antman, L. Parsons Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3 JAMA 286 2001 1356 1359
26. M. Singh, R.J. Lennon, D.R. Holmes Jr, M.R. Bell, C.S. Rihal Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention J Am Coll Cardiol 40 2002 387 393
27. J.G. Webb, L.A. Sleeper, C.E. Buller Implications of the timing of onset of cardiogenic shock after acute myocardial infarction a report from the SHOCK Trial Registry SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36 2000 1084 1090
28. M.E. Khalil, A.W. Basher, E.J. Brown Jr, I.A. Alhaddad A remarkable medical story benefits of angiotensin-converting enzyme inhibitors in cardiac patients J Am Coll Cardiol 37 2001 1757 1764
29. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction the CAPRICORN randomised trial Lancet 357 2001 1385 1390
30. A.J. Moss, W. Zareba, W.J. Hall Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
31. S.H. Hohnloser, B.J. Gersh Changing late prognosis of acute myocardial infarction impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator Circulation 107 2003 941 946
32. M.T. Roe, F.A. Cura, P.S. Joski Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction Am J Cardiol 88 2001 170 173
33. W.C. Wu, S.S. Rathore, Y. Wang, M.J. Radford, H.M. Krumholz Blood transfusion in elderly patients with acute myocardial infarction N Engl J Med 345 2001 1230 1236
34. G.C. Curhan Prevention of contrast nephropathy JAMA 289 2003 606 608
35. R. Birck, S. Krzossok, F. Markowetz, P. Schnulle, F.J. van der Woude, C. Braun Acetylcysteine for prevention of contrast nephropathy meta-analysis Lancet 362 2003 598 603
36. G.J. Merten, W.P. Burgess, L.V. Gray Prevention of contrast-induced nephropathy with sodium bicarbonate a randomized controlled trial JAMA 291 2004 2328 2334
37. D. Antoniucci, R. Valenti, A. Migliorini Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation Am J Cardiol 90 2002 353 357
38. S. Giri, J. Mitchel, R.R. Azar Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock Am J Cardiol 89 2002 126 131
39. B.A. Vakili, R. Kaplan, D.L. Brown Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state Circulation 104 2001 2171 2176
40. A.W. van't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
41. B.R. Brodie, D.A. Cox, T.D. Stuckey How important is time to treatment with primary percutaneous coronary intervention for acute myocardial infarction (abstr)? J Am Coll Cardiol 41 Suppl 5 2003 368A